Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting cancer using KAT inhibitors to mimic lethal knockouts
James A. L. Brown, Emer Bourke, Leif A. Eriksson, et al.
Biochemical Society Transactions (2016) Vol. 44, Iss. 4, pp. 979-986
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases
Shruti Mishra, Sumit Singh Verma, Vipin Rai, et al.
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 10, pp. 1947-1966
Open Access | Times Cited: 204
Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer
Peter McAnena, James A. L. Brown, Michael J. Kerin
Cancers (2017) Vol. 9, Iss. 1, pp. 5-5
Open Access | Times Cited: 98
The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy
Yunkai Yang, Min Zhang, Yan Wang
Journal of the National Cancer Center (2022) Vol. 2, Iss. 4, pp. 277-290
Open Access | Times Cited: 59
Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update
Pere Llinàs‐Arias, Manel Esteller
Open Biology (2017) Vol. 7, Iss. 9, pp. 170152-170152
Open Access | Times Cited: 81
Epigenetic modulators as therapeutic targets in prostate cancer
Inês Graça, Eva Pereira-Silva, Rui Henrique, et al.
Clinical Epigenetics (2016) Vol. 8, Iss. 1
Open Access | Times Cited: 74
Ketamine suppresses proliferation and induces ferroptosis and apoptosis of breast cancer cells by targeting KAT5/GPX4 axis
Huixin Li, Wei Liu, Xiaoyu Zhang, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 585, pp. 111-116
Closed Access | Times Cited: 50
Polo-Like Kinase 4’s Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy
Xiaoyang Zhang, Cheng Wei, Hao Liang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 47
Transcriptional Repression of Ferritin Light Chain Increases Ferroptosis Sensitivity in Lung Adenocarcinoma
Yikun Wang, Shiyu Qiu, Hong Wang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 41
Current trends in clinical trials and the development of small molecule epigenetic inhibitors as cancer therapeutics
Nazanin Zohourian, James A. L. Brown
Epigenomics (2024) Vol. 16, Iss. 9, pp. 671-680
Closed Access | Times Cited: 5
Lifespan-increasing drug nordihydroguaiaretic acid inhibits p300 and activates autophagy
Tuğsan Tezil, Manish Chamoli, Che-Ping Ng, et al.
npj Aging and Mechanisms of Disease (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 37
Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond
Jianwei Feng, Xinyue Meng
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22
Transcriptomic and genomic studies classify NKL54 as a histone deacetylase inhibitor with indirect influence on MEF2-dependent transcription
Martina Minisini, Eros Di Giorgio, Emanuela Kerschbamer, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 5, pp. 2566-2586
Open Access | Times Cited: 19
TIP60 is required for tumorigenesis in non‐small cell lung cancer
Daisuke Shibahara, Naoki Akanuma, Ikei S. Kobayashi, et al.
Cancer Science (2023) Vol. 114, Iss. 6, pp. 2400-2413
Open Access | Times Cited: 11
Epigenetic Modulations in Breast Cancer: An Emerging Paradigm in Therapeutic Implications
Shilpi Sarkar, Dheepika Venkatesh, Thirukumaran Kandasamy, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 8
Open Access | Times Cited: 4
Mitigation of Injury from Myocardial Infarction by Pentamidine, an Inhibitor of the Acetyltransferase Tip60
Xinrui Wang, Katherine R Harty, Tina C. Wan, et al.
Cardiovascular Drugs and Therapy (2025)
Closed Access
Exploiting Epigenetic Alterations in Prostate Cancer
Simon J. Baumgart, Bernard Haendler
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 5, pp. 1017-1017
Open Access | Times Cited: 37
Recurrent chromosomal translocations in sarcomas create a megacomplex that mislocalizes NuA4/TIP60 to Polycomb target loci
Deepthi Sudarshan, Nikita Avvakumov, Marie‐Eve Lalonde, et al.
Genes & Development (2022) Vol. 36, Iss. 11-12, pp. 664-683
Open Access | Times Cited: 17
Quantifying Tip60 (Kat5) stratifies breast cancer
Andrew McGuire, Máire‐Caitlín Casey, Aliaa Shalaby, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 26
NU9056, a KAT 5 Inhibitor, Treatment Alleviates Brain Dysfunction by Inhibiting NLRP3 Inflammasome Activation, Affecting Gut Microbiota, and Derived Metabolites in LPS-Treated Mice
Lu Chen, Wenxiang Qing, Zexiong Yi, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 22
NDUFA4L2 is associated with clear cell renal cell carcinoma malignancy and is regulated by ELK1
Lei Wang, Zhiqiang Peng, Kaizhen Wang, et al.
PeerJ (2017) Vol. 5, pp. e4065-e4065
Open Access | Times Cited: 27
Aspirin Suppressed PD-L1 Expression through Suppressing KAT5 and Subsequently Inhibited PD-1 and PD-L1 Signaling to Attenuate OC Development
Xiyun Xiao, Saitian Zeng, Yanying Li, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 13
Targeting Histone Epigenetic Modifications and DNA Damage Responses in Synthetic Lethality Strategies in Cancer?
Pedro A. Lazo
Cancers (2022) Vol. 14, Iss. 16, pp. 4050-4050
Open Access | Times Cited: 13
Evaluating the Cellular Roles of the Lysine Acetyltransferase Tip60 in Cancer: A Multi-Action Molecular Target for Precision Oncology
Nazanin Zohourian, Erin Coll, Muiread Dever, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2677-2677
Open Access | Times Cited: 2
Clinically Applicable Inhibitors Impacting Genome Stability
Anu Prakash, Juan F. García-Moreno, James A. L. Brown, et al.
Molecules (2018) Vol. 23, Iss. 5, pp. 1166-1166
Open Access | Times Cited: 23
Circular RNA circRHOT1 contributes to pathogenesis of non-small cell lung cancer by epigenetically enhancing C-MYC expression through recruiting KAT5
Xiaoyan Ren, Jiangang Yu, Lili Guo, et al.
Aging (2021) Vol. 13, Iss. 16, pp. 20372-20382
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top